Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Egoavil

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Gastroenterology|November 8, 2017
ReplyMiriam Juárez, Cecilia Egoavil, Rodrigo Jover
World Journal of Gastroenterology|April 8, 2016
Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapyOscar Murcia, Miriam Juárez, Eva Hernández-Illán, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot StudyLaura de Miguel, Pura Ballester, Cecilia Egoavil, et al.
Plos One|August 16, 2014
IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancerLucia Perez-Carbonell, Francesc Balaguer, Yuji Toiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
<i>TFAP2E</i> Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal CancerOscar Murcia, Rodrigo Jover, Cecilia Egoavil, et al.
American Journal of Cancer Research|January 29, 2015
Methylation of tumor suppressor genes is related with copy number aberrations in breast cancerRosa Murria, Sarai Palanca, Inmaculada de Juan, et al.
Plos One|February 1, 2012
TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancerAna Martinez-Canto, Adela Castillejo, Trinidad Mata-Balaguer, et al.
American Journal of Cancer Research|September 2, 2015
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicineRosa Murria, Sarai Palanca, Inmaculada de Juan, et al.
Plos One|September 7, 2018
Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapyOscar Murcia, Míriam Juárez, María Rodríguez-Soler, et al.
Breast Cancer Research and Treatment|October 17, 2013
MicroRNA signatures in hereditary breast cancerRosa Murria Estal, Sarai Palanca Suela, Inmaculada de Juan Jiménez, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gastroenterology|November 8, 2017
ReplyMiriam Juárez, Cecilia Egoavil, Rodrigo Jover
World Journal of Gastroenterology|April 8, 2016
Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapyOscar Murcia, Miriam Juárez, Eva Hernández-Illán, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot StudyLaura de Miguel, Pura Ballester, Cecilia Egoavil, et al.
Plos One|August 16, 2014
IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancerLucia Perez-Carbonell, Francesc Balaguer, Yuji Toiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
<i>TFAP2E</i> Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal CancerOscar Murcia, Rodrigo Jover, Cecilia Egoavil, et al.
American Journal of Cancer Research|January 29, 2015
Methylation of tumor suppressor genes is related with copy number aberrations in breast cancerRosa Murria, Sarai Palanca, Inmaculada de Juan, et al.
Plos One|February 1, 2012
TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancerAna Martinez-Canto, Adela Castillejo, Trinidad Mata-Balaguer, et al.
American Journal of Cancer Research|September 2, 2015
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicineRosa Murria, Sarai Palanca, Inmaculada de Juan, et al.
Plos One|September 7, 2018
Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapyOscar Murcia, Míriam Juárez, María Rodríguez-Soler, et al.
Breast Cancer Research and Treatment|October 17, 2013
MicroRNA signatures in hereditary breast cancerRosa Murria Estal, Sarai Palanca Suela, Inmaculada de Juan Jiménez, et al.
Pageof 2